LB Pharmaceuticals, Inc. (LBRX)
48.25
-0.55
(-1.13%)
USD |
NASDAQ |
Aug 26, 12:11
LB Pharmaceuticals Price : 48.25 for Aug. 26, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 25, 2026 | 48.70 | 50.16 | 48.48 | 48.80 | 217026.0 |
| Aug 24, 2026 | 47.88 | 49.06 | 46.83 | 48.21 | 252690.0 |
| Aug 21, 2026 | 47.71 | 48.21 | 46.34 | 47.62 | 225828.0 |
| Aug 20, 2026 | 48.51 | 48.86 | 46.90 | 47.23 | 194528.0 |
| Aug 19, 2026 | 49.80 | 49.97 | 48.24 | 48.94 | 162252.0 |
| Aug 18, 2026 | 45.69 | 48.93 | 45.69 | 48.77 | 540387.0 |
| Aug 17, 2026 | 47.10 | 47.96 | 46.11 | 46.23 | 261785.0 |
| Aug 14, 2026 | 44.24 | 47.88 | 43.64 | 47.78 | 295402.0 |
| Aug 13, 2026 | 46.00 | 46.15 | 44.02 | 44.27 | 432903.0 |
| Aug 12, 2026 | 45.32 | 46.01 | 44.03 | 45.38 | 355992.0 |
| Aug 11, 2026 | 45.93 | 46.27 | 43.61 | 45.33 | 235758.0 |
| Aug 10, 2026 | 47.68 | 48.94 | 43.91 | 45.85 | 425932.0 |
| Aug 07, 2026 | 48.81 | 49.14 | 47.42 | 48.00 | 269180.0 |
| Aug 06, 2026 | 45.00 | 48.55 | 44.53 | 48.18 | 465654.0 |
| Aug 05, 2026 | 45.31 | 45.75 | 44.02 | 45.03 | 317746.0 |
| Aug 04, 2026 | 42.99 | 46.00 | 42.56 | 45.00 | 563749.0 |
| Aug 03, 2026 | 40.74 | 44.33 | 39.01 | 42.84 | 872095.0 |
| Jul 31, 2026 | 40.39 | 40.67 | 38.98 | 40.08 | 339016.0 |
| Jul 30, 2026 | 39.27 | 41.33 | 36.72 | 40.90 | 513949.0 |
| Jul 29, 2026 | 35.14 | 39.26 | 35.14 | 39.00 | 709305.0 |
| Jul 28, 2026 | 34.83 | 38.62 | 34.68 | 34.94 | 290610.0 |
| Jul 27, 2026 | 35.22 | 36.31 | 34.03 | 34.78 | 217913.0 |
| Jul 24, 2026 | 34.89 | 35.93 | 34.11 | 35.01 | 333825.0 |
| Jul 23, 2026 | 35.85 | 36.30 | 33.80 | 34.62 | 594397.0 |
| Jul 22, 2026 | 33.26 | 36.60 | 32.60 | 35.84 | 799245.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Ligand Pharmaceuticals, Inc. | 286.51 |
| Neumora Therapeutics, Inc. | 1.53 |
| ANI Pharmaceuticals, Inc. | 74.53 |
| Corcept Therapeutics, Inc. | 122.73 |
| Veru, Inc. | 2.74 |
Price Related Metrics
| PEG Ratio | -0.1226 |
| Price to Book Value | 4.164 |
| Earnings Yield | -6.18% |
| Market Cap | 1.384B |
| PEGY Ratio | -0.1226 |